About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT02982993

Hepatitis C Infection in World Trade Center Responders

This study provides Hepatitis C virus screening to the members of the World Trade Center Health Program followed at the Icahn School of Medicine at Mount Sinai born during 1945-1965, and linkage to ca...

Lead sponsor: Icahn School of Medicine at Mount Sinai•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

Centers for Disease Control and Prevention
National Institute for Occupational Safety and Health (NIOSH/CDC)

The purpose of the project is to determine if the World Trade Center Health Program cohort is at an increased risk of Hepatitis C virus infection, determine if human exposure to human remains, blood and/or body fluids during the World Trade Center recovery activities is associated with increased risk of Hepatitis C virus infection, and to determine if referral to a co-located site for Hepatitis C virus care is associated with improved linkage to Hepatitis C virus care in the members of the World Trade Center Health Program born during 1945 through 1965.

Age

51 - 72 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Member of the World Trade Center Health Program at the Icahn School of Medicine at Mount Sinai
•Born during 1945-1965

Exclusion Criteria

•None

Related studies

TERMINATEDPhase 3

Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV

NCT01866930 · Chronic Hepatitis C Infection

Rapid Diagnostics for HIV and Hepatitis

NCT02190305 · HIV Infections, Hepatitis B Infections, and more

Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions

NCT02333292 · Chronic Hepatitis C Infection

COMPLETEDPhase 2

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

NCT00991289 · HIV Infection, Hepatitis C Infection

COMPLETEDPhase 3

A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults

NCT02582632 · Hepatitis C Infection, Hepatitis C Virus

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 4, 2019Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment3,906

Start dateDec 2016

Last updatedFeb 4, 2019

Condition

Hepatitis C Infection

Locations shown

Icahn School of Medicine at Mount Sinai

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 4, 2019Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions